← Back to Clinical Trials
Recruiting NCT07191782

NCT07191782 Examining the Efficacy of the PRAISE With Coaching Program

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07191782
Status Recruiting
Phase —
Sponsor Children's Hospital of Philadelphia
Condition Aggression Childhood
Study Type INTERVENTIONAL
Enrollment 1,008 participants
Start Date 2025-09-26
Primary Completion 2028-06-30

Eligibility & Interventions

Sex All sexes
Min Age 8 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Universal, classroom-based, Bullying and Aggression Prevention Program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 1,008 participants in total. It began in 2025-09-26 with a primary completion date of 2028-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The PReventing Aggression In Schools Everyday (PRAISE) Program has evidence of impact when run by research staff. PRAISE was adapted using community-based participatory research to a coaching model whereby school-staff are trained to facilitate the program and receive ongoing coaching from research staff. The overall objective is to demonstrate the efficacy of the adapted PRAISE program when facilitated by in-school staff.

Eligibility Criteria

Student Inclusion Criteria: * Enrolled in one of the participating school sites * In a 3rd-5th grade classroom participating in the study Staff Inclusion Criteria: * Employed by one of the participating school sites * Teach and/or provide services to students in 3rd-5th grade Students Exclusion Criteria: * Do not speak English * Special education students not integrated in a regular education classroom * Student not in Grades 3-5 at the participating school sites Teacher Exclusion Criteria: * Do not speak English * Do not teach/provide services with 3rd-5th grade students at the participating school sites

Contact & Investigator

Central Contact

Tracy E Waasdorp, PhD MSed

✉ waasdorpt@chop.edu

📞 2676370861

Principal Investigator

Tracy E Waasdorp, PhD MSEd

PRINCIPAL INVESTIGATOR

Children's Hospital of Philadelphia

Frequently Asked Questions

Who can join the NCT07191782 clinical trial?

This trial is open to participants of all sexes, aged 8 Years or older, studying Aggression Childhood. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07191782 currently recruiting?

Yes, NCT07191782 is actively recruiting participants. Contact the research team at waasdorpt@chop.edu for enrollment information.

Where is the NCT07191782 trial being conducted?

This trial is being conducted at Philadelphia, United States.

Who is sponsoring the NCT07191782 clinical trial?

NCT07191782 is sponsored by Children's Hospital of Philadelphia. The principal investigator is Tracy E Waasdorp, PhD MSEd at Children's Hospital of Philadelphia. The trial plans to enroll 1,008 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology